chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphoedema
Clinical narrative: Lymphedema right collar; This is a spontaneous report from a contactable nurse, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30130BA) via an unspecified route of administration in the right arm on 17Sep2021 at 16:30 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176), via an unspecified route of administration in the left arm on 16Aug2021 at 16:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 18Sep2021 at 04:00, the patient experienced lymphedema right collar. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event lymphedema right collar was not resolved at the time of this report.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Hypoaesthesia, Pain in extremity
Clinical narrative: Continue to have pain and numbness to left arm.; Continue to have pain and numbness to left arm.; Chest pain on left side; This is a spontaneous report from a contactable other healthcare professional, the patient. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 01Sep2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 09Aug2021 at 15:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 01Sep2021 at 15:00, the patient continued to had pain and numbness to left arm. The patient also had chest pain on left side. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events continue to have pain and numbness to left arm and chest pain on left side was not recovered at the time of this report.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Back pain, Body temperature, Diarrhoea, Fatigue
Clinical narrative: Arm sore; Fever of 102 for 2 days; Back aches; Diarrhea/upset stomach; Diarrhea/upset stomach; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 15Sep2021 at 16:45 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included drospirenone/ ethinylestradiol betadex clathrate (YAZ) started from an unknown date taken daily for birth control. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the left arm on 27Aug2021 at 15:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 16Sep2021 at 13:15, the patient experienced arm sore, fever of 102 for 2 days, back aches, diarrhea/upset stomach, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 16Sep2021, the patient underwent lab test body temperature and the result was 102 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm sore, back aches, diarrhea/upset stomach, headache and fatigue were resolved on an unknown date in Sep2021; while the event fever of 102 for 2 days was resolved on 18Sep2021, after the duration of 2 days.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pyrexia
Clinical narrative: Arm sore; Fever of 102 for 2 days; Back aches; Diarrhea/upset stomach; Diarrhea/upset stomach; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 15Sep2021 at 16:45 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included drospirenone/ ethinylestradiol betadex clathrate (YAZ) started from an unknown date taken daily for birth control. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the left arm on 27Aug2021 at 15:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 16Sep2021 at 13:15, the patient experienced arm sore, fever of 102 for 2 days, back aches, diarrhea/upset stomach, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 16Sep2021, the patient underwent lab test body temperature and the result was 102 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm sore, back aches, diarrhea/upset stomach, headache and fatigue were resolved on an unknown date in Sep2021; while the event fever of 102 for 2 days was resolved on 18Sep2021, after the duration of 2 days.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Sciatica
Clinical narrative: Sciatic nerve pain; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the arm right on 19Sep2021 at 11:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (ACETAMINOPHEN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the arm right on 22Aug2021 at 10:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. On 19Sep2021 at 23:00, the patient experienced sciatic nerve pain. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sciatic nerve pain was not resolved at the time of this report.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Delusion, Fatigue, Hypersomnia, Nausea, SARS-CoV-2 test
Clinical narrative: "I" started to feel really tired; Had a delusion of seeing balloons on the road; "I" started to feel nauseated; "I" slept for about 16-19 hours; This is a spontaneous report from a contactable nurse, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2088) via intramuscular route of administration in the left arm on 17Sep2021 at 19:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 21Aug2021, the patient underwent nasal swab test for COVID-19 and the result was negative. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via intramuscular route of administration in the right arm on 27Aug2021 at 19:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. In the morning on 18Sep2021 (saturday), the patient felt fine. After having lunch on 18Sep2021, the patient started to feel nauseated and about forty minutes after, she started to feel really tired and had a delusion of seeing balloons on the road. The patient's husband was driving in the car and she asked if he saw what she saw and he told no. Once they were home, the patient slept for about 16 to19 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events "I" started to feel nauseated, "I" started to feel really tired and had a delusion of seeing balloons on the road was resolved on an unspecified date in Sep2021 while the clinical outcome of the event "I" slept for about 16-19 hours was resolved on 19Sep2021.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Hypoaesthesia oral, Lip swelling, Neck pain
Clinical narrative: Pain in left neck from shoulder to ear for 48 hours; Diarrhea; Swollen & Numb lips; Swollen & Numb lips; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 3182) via an unspecified route of administration in the left arm on 30Aug2021 at 18:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient's medical history reported as not applicable. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were reported as N/A. On 30Aug2021 at 20:00, the patient experienced pain in left neck from shoulder to ear for 48 hours, diarrhea for 24 hours and swollen and numb lips for 48 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diarrhea was resolved on 31Aug2021, after the duration of 24 hours; while that of the events pain in left neck from shoulder to ear and swollen and numb lips were resolved on 01Sep2021, after the duration of 48 hours.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus
Clinical narrative: Left arm itches right where the injections site is and aches like a tooth ache; Left arm itches right where the injections site is and aches like a tooth ache; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 07Sep2021 at 10:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), colecalciferol (VITAMIN D3), montelukast sodium (SINGULAIR), unspecified probiotics and cholesterol pill; all for unknown indication from unknown date and unknown if ongoing. On 07Sep2021 at 11:00, the patient's left arm was itching right where the injections site was and ached like a tooth ache. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm itches right where the injections site is and aches like a tooth ache was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Ear pain, Headache, Joint swelling
Clinical narrative: Right ankle swollen for 2 days; Body aches; Fever of 101; Extreme headache; Sore throat; Ear ache; Hives; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301308A) via an unspecified route of administration in the left arm on 17Sep2021 at 12:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  Concomitant medications included acyclovir (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PC3183) via an unspecified route of administration in the left arm on 27Aug2021 at 11:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 18Sep2021 at 06:00, the patient had right ankle swollen for 2 days, body aches, fever of 101, extreme headache, sore throat, ear ache, hives and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event right ankle swollen for 2 days was resolved on an unknown date in Sep2021 while that of the events body aches, fever of 101, extreme headache, sore throat, ear ache, hives and dizziness was not resolved at the time of the report.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia, Urticaria
Clinical narrative: Right ankle swollen for 2 days; Body aches; Fever of 101; Extreme headache; Sore throat; Ear ache; Hives; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301308A) via an unspecified route of administration in the left arm on 17Sep2021 at 12:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  Concomitant medications included acyclovir (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PC3183) via an unspecified route of administration in the left arm on 27Aug2021 at 11:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 18Sep2021 at 06:00, the patient had right ankle swollen for 2 days, body aches, fever of 101, extreme headache, sore throat, ear ache, hives and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event right ankle swollen for 2 days was resolved on an unknown date in Sep2021 while that of the events body aches, fever of 101, extreme headache, sore throat, ear ache, hives and dizziness was not resolved at the time of the report.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Nausea
Clinical narrative: Nausea; Vomiting; Headache; Fever; Body aches; Chills; Joint pain, hip pain; Spinal pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 15Sep2021 at 07:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ocrelizumab (OCREVUS) and fluvoxamine maleate (LUVOX); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on an unknown date in Aug2021 at 07:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient previously also received azithromycin (ZITHROMAX) and gadolinium (MANUFACTURER UNKNOWN) and experienced drug allergy. On 15Sep2021 at 15:00, the patient experienced nausea, vomiting, headache, fever, body aches, chills, joint pain, hip pain, spinal pain and fatigue. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, vomiting, headache, fever, body aches, chills, joint pain, hip pain, spinal pain and fatigue was recovered with sequelae (reported as recovered with lasting effects) on an unknown date in Sep2021.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Spinal pain, Vomiting
Clinical narrative: Nausea; Vomiting; Headache; Fever; Body aches; Chills; Joint pain, hip pain; Spinal pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 15Sep2021 at 07:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ocrelizumab (OCREVUS) and fluvoxamine maleate (LUVOX); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on an unknown date in Aug2021 at 07:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient previously also received azithromycin (ZITHROMAX) and gadolinium (MANUFACTURER UNKNOWN) and experienced drug allergy. On 15Sep2021 at 15:00, the patient experienced nausea, vomiting, headache, fever, body aches, chills, joint pain, hip pain, spinal pain and fatigue. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, vomiting, headache, fever, body aches, chills, joint pain, hip pain, spinal pain and fatigue was recovered with sequelae (reported as recovered with lasting effects) on an unknown date in Sep2021.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Heavy menstrual bleeding, Hot flush, Malaise
Clinical narrative: Upper extremity swelling; Neck swelling; Headache; General fatigue; Malaise; Menstrual irregularity including long menstruation (15 days); Menstrual irregularity including long menstruation (15 days); Hot flashes; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration on 23Jun2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included scoliosis, premenstrual syndrome (PMS) and allergy to sulfa drugs. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included fluoxetine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 23Jun2021 at 22:00, the patient experienced upper extremity swelling, neck swelling, headache, general fatigue and malaise. The patient also reported menstrual irregularity including long menstruation (15 days) and hot flashes. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 24Jul2021, the patient underwent polymerase chain reaction (PCR) test via nasal swab and the result was negative. The clinical outcome of the events upper extremity swelling, neck swelling, headache, general fatigue, malaise, menstrual irregularity including long menstruation (15 days) and hot flashes was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular, Peripheral swelling, SARS-CoV-2 test, Swelling
Clinical narrative: Upper extremity swelling; Neck swelling; Headache; General fatigue; Malaise; Menstrual irregularity including long menstruation (15 days); Menstrual irregularity including long menstruation (15 days); Hot flashes; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration on 23Jun2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included scoliosis, premenstrual syndrome (PMS) and allergy to sulfa drugs. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included fluoxetine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 23Jun2021 at 22:00, the patient experienced upper extremity swelling, neck swelling, headache, general fatigue and malaise. The patient also reported menstrual irregularity including long menstruation (15 days) and hot flashes. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 24Jul2021, the patient underwent polymerase chain reaction (PCR) test via nasal swab and the result was negative. The clinical outcome of the events upper extremity swelling, neck swelling, headache, general fatigue, malaise, menstrual irregularity including long menstruation (15 days) and hot flashes was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding
Clinical narrative: Extremely heavy and long periods; Along with worst cramps "I" have ever experienced.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 11May2021 at 08:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks of vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 20Apr2021 at 08:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On an unknown date in May2021, the patient had extremely heavy and long periods along with worst cramps that patient had ever experienced. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely heavy and long periods along with worst cramps was unknown at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer or other non-HCP (patient's daughter). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on Feb2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient's daughter stated her mom received the Pfizer vaccine in Feb2021 at a different location and she never reported back about symptoms, but she got shingles after her second dose on an unspecified date 2021. The outcome of the event was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain
Clinical narrative: Swollen Lymph Nodes; Pain; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 17Aug2021 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. The patient previously received amoxicillin (AMOXICILLINE) on an unknown date for an unknown indication and experienced drug allergy. On 17Aug2021, the patient experienced swollen lymph nodes and pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph nodes and pain were resolved on an unknown date in 2021.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chest pain, Heart rate, Heart rate increased
Clinical narrative: pulse was 118; slight, slight chest pain/she had chest pain so bad it almost took her to the floor; This is a spontaneous report from a contactable consumer (patient) reported for herself. A female patient of an unspecified age received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (also reported as on the 15th) (age at vaccination was unknown) as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the Pfizer COVID vaccine on the 15th. On an unspecified date, the patient experienced slight, slight chest pain that day. The following day, she had chest pain so bad it almost took her to the floor and caused her to be hunched over holding her chest. It lasted for about 4 min. She went home after that and measured her blood pressure and pulse and noted her blood pressure was okay, but her pulse was 118 on an unspecified date. The outcome of the event slight, slight chest pain/she had chest pain so bad it almost took her to the floor was resolved on an unspecified date in 2021. The outcome of the event pulse was 118 was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dizziness, Dyspnoea, High-pitched crying, Wheezing
Clinical narrative: Major dizziness; Breathing like a fish out of water; Wheezing; Squeaking; Coughing; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 03Sep2021 at 08:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid, allergy to lots of things, environmental, food, and chemical allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ARMOUR THYROID and LORATSDINE for an unknown indication from an unknown date and unknown if ongoing. On 03Sep2021, the patient experienced major dizziness within 2 minutes of injection which lasted continually for 5 hours, intermittently for 7 days with breathing like a fish out of water, wheezing, squeaking and coughing started an hour after injection and was continued badly for an hour, reasonably for 2 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included ALBUTEROL inhaler 2 times, hot packs, hot tea, and bed. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events major dizziness, breathing like a fish out of water, wheezing, squeaking and coughing was resolved with lasting effects on an unknown date in Sep2021 at the time of report. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea
Clinical narrative: No menstrual cycle after vaccine; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Aug2021 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Aug2021, the patient experienced no menstrual cycle after vaccine. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event no menstrual cycle after vaccine was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Gait inability, Posture abnormal
Clinical narrative: Lost all ability to sit upright; Lost ability to stand; Lost ability to walk; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic depression and known allergies to antibiotics. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 24Feb2021 at 13:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 17Mar2021 at 18:00, the patient lost all ability to sit upright, lost ability to stand and lost ability to walk, which lasted about 14 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lost all ability to sit upright, lost ability to stand and lost ability to walk was recovered with sequelae on 18Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Dizziness, Menstruation irregular, Muscle spasms, Ultrasound scan
Clinical narrative: Developed period like cramps for a whole month; Being light-headed frequently; In addition her cycle became irregular resulting in 5 months of missed period, this was not normal due to having regular cycles, to this day Sep2021 she still had missing and or skipping months of periods; This is a spontaneous report from a contactable other healthcare professional, the patient. A 25-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the right arm on an unknown date in Jan2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via an unspecified route of administration in the left arm on 31Dec2020 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Mar2021, after second dose of vaccination, the patient developed period like cramps for a whole month. Then she was being light headed frequently. In addition, her cycle became irregular resulting in 5 months of missed period. This was not normal due to having regular cycles. It was reported that, to this day Sep2021 the patient was still missing and or skipping months of periods. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included lab tests with ultrasound and blood work on an unknown date in 2021 and results were unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events developed period like cramps for a whole month and being light headed frequently was unknown; whereas for event and cycle became irregular resulting in 5 months of missed period, this was not normal due to having regular cycles, to this day Sep2021 she still had missing and or skipping months of periods was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Headache, Hot flush
Clinical narrative: Bad headaches; Extreme fatigue; Hot flashes; Vertigo; Weakness; Left hand to left elbow tingling; Left hand to left elbow tingling with pain; Left hand to left elbow tingling with pain; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 08Sep2021 at 14:30 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), amitriptyline (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and alendronate sodium (ALENDRONAT) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Sep2021 at 09:00 the patient experienced bad headaches, extreme fatigue, hot flashes, vertigo, weakness, left hand to left elbow tingling, left elbow pain and left-hand pain. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events bad headaches, extreme fatigue, hot flashes, vertigo, weakness, left hand to left elbow tingling, left elbow pain and left hand pain were not recovered at the time of this report.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Vertigo
Clinical narrative: Bad headaches; Extreme fatigue; Hot flashes; Vertigo; Weakness; Left hand to left elbow tingling; Left hand to left elbow tingling with pain; Left hand to left elbow tingling with pain; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 08Sep2021 at 14:30 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), amitriptyline (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and alendronate sodium (ALENDRONAT) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Sep2021 at 09:00 the patient experienced bad headaches, extreme fatigue, hot flashes, vertigo, weakness, left hand to left elbow tingling, left elbow pain and left-hand pain. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events bad headaches, extreme fatigue, hot flashes, vertigo, weakness, left hand to left elbow tingling, left elbow pain and left hand pain were not recovered at the time of this report.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Decreased appetite, Depression, Headache
Clinical narrative: Headache; Low grade fever; Nausea; Depression; Weak; No appetite; Cough; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 24Aug2021 at 09:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously took ranitidine hydrochloride (ZANTAC) and morphine sulfate (MORPHINE) and experienced drug allergy. On 25Aug2021 at 07:00, the patient experienced headache, low grade fever, nausea, depression, weak, no appetite and cough. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 27Aug2021, the patient underwent nasal swab test for COVID-19 and the result was positive. On 10Sep2021, the patient underwent nasal swab test for COVID-19 and the result was negative. The clinical outcome of the events headache, low grade fever, nausea, depression, weak, no appetite and cough was resolved with sequelae (reported as patient recovered with lasting effects) on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: Headache; Low grade fever; Nausea; Depression; Weak; No appetite; Cough; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 24Aug2021 at 09:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously took ranitidine hydrochloride (ZANTAC) and morphine sulfate (MORPHINE) and experienced drug allergy. On 25Aug2021 at 07:00, the patient experienced headache, low grade fever, nausea, depression, weak, no appetite and cough. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 27Aug2021, the patient underwent nasal swab test for COVID-19 and the result was positive. On 10Sep2021, the patient underwent nasal swab test for COVID-19 and the result was negative. The clinical outcome of the events headache, low grade fever, nausea, depression, weak, no appetite and cough was resolved with sequelae (reported as patient recovered with lasting effects) on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Body temperature, Epistaxis, Fatigue, Headache
Clinical narrative: Severe headache; Blurred vision; Elevated blood pressure; Nausea; Injection site severe swelling; Fever; Body aches; Tiredness; Underarm/breast lymph nodes swelling; Nose bleed only from left nostril; This is a spontaneous report from a contactable healthcare professional, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 13Sep2021 at 15:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as not applicable. The patient had unspecified allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Sep2021 at 15:00 (reported as Day 01), the patient experienced injection site severe swelling, fever 100.5 (unspecified units), body aches, severe headache, blurred vision, elevated blood pressure, nausea, and tiredness. On an unknown date in Sep2021 (reported as Day 02-04), the patient experienced underarm/breast lymph nodes swelling, severe headache, nausea and tiredness. On an unknown date in Sep2021 the patient experienced nose bleed only from left nostril and continued severe headaches from 15Sep2021 (reported as Day 03) to present (at the time of this report). Therapeutic measures were taken as a result of the events nausea, headache, lymph node swelling and nose bleed. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department visit or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site severe swelling, fever 100.5, body aches, blurred vision, elevated blood pressure, nausea, tiredness, underarm/breast lymph nodes swelling and nose bleed only from left nostril was recovering while the outcome of severe headaches was not recovered at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.